Literature DB >> 15131473

Refractory Kawasaki disease.

Alexandra F Freeman1, Stanford T Shulman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15131473     DOI： 10.1097/01.inf.0000125893.66941.e0

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  11 in total

Review 1.  Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease.

Authors:  Seyyedeh Saneeymehri; Katherine Baker; Tsz-Yin So
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

2.  Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.

Authors:  Adriana H Tremoulet; Paige Pancoast; Alessandra Franco; Matthew Bujold; Chisato Shimizu; Yoshihiro Onouchi; Alyson Tamamoto; Guliz Erdem; Debra Dodd; Jane C Burns
Journal:  J Pediatr       Date:  2012-04-06       Impact factor: 4.406

3.  Recent advances in the understanding and management of kawasaki disease.

Authors:  Anne H Rowley; Stanford T Shulman
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

4.  Predicting factors for refractory kawasaki disease.

Authors:  Young-Sun Do; Ki-Won Kim; Jin-Kyong Chun; Byung Ho Cha; Mee Kyung Namgoong; Hae Yong Lee
Journal:  Korean Circ J       Date:  2010-05-27       Impact factor: 3.243

5.  Infliximab treatment for refractory kawasaki disease in korean children.

Authors:  Min Seob Song; Sang Bum Lee; Sejung Sohn; Jin Hee Oh; Kyung Lim Yoon; Ji Whan Han; Chul Ho Kim
Journal:  Korean Circ J       Date:  2010-07-26       Impact factor: 3.243

6.  Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor.

Authors:  Yunku Yeo; TaeYeon Kim; KeeSoo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2008-05-14       Impact factor: 3.183

7.  Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.

Authors:  DooIl Song; Yunku Yeo; KeeSoo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2009-01-22       Impact factor: 3.183

Review 8.  Pathogenesis and management of Kawasaki disease.

Authors:  Anne H Rowley; Stanford T Shulman
Journal:  Expert Rev Anti Infect Ther       Date:  2010-02       Impact factor: 5.091

Review 9.  Kawasaki disease: laboratory findings and an immunopathogenesis on the premise of a "protein homeostasis system".

Authors:  Kyung-Yil Lee; Jung-Woo Rhim; Jin-Han Kang
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

10.  Catastrophic Kawasaki disease unresponsive to IVIG in a 3-month-old infant: a diagnostic and therapeutic challenge.

Authors:  Cristina Medeiros Ribeiro de Magalhães; Natália Ribeiro de Magalhães Alves; Adriana Valença de Melo; Clodoaldo Abreu da Silveira Junior; Yanna Karla de Medeiros Nόbrega; Lenora Gandolfi; Riccardo Pratesi
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-28       Impact factor: 3.054
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.